Weekly Recap: AX-0811 clinical trial start and ProQR AI leadership hires
ProQR Therapeutics N.V. (NASDAQ:PRQR) is fast-tracking AI-discovered AX-0811 into clinical trials with target-engagement data due in early Jan 2027 while advancing AX-0422 and AX-2911 toward the clinic, bolstered by Ginkgo collaboration and new AI hires Chris Hart and advisor Thomas Wolf.Previous W…